• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives.针对美国印第安人/阿拉斯加原住民的阿片类药物使用障碍的药物辅助治疗的未来方向。
Addict Behav. 2018 Nov;86:111-117. doi: 10.1016/j.addbeh.2018.05.017. Epub 2018 May 23.
2
Statewide collaborative partnerships among American Indian and Alaska Native (AI/AN) communities in California to target the opioid epidemic: Preliminary results of the Tribal Medication Assisted Treatment (MAT) key informant needs assessment.加利福尼亚州美洲印第安人和阿拉斯加原住民(AI/AN)社区之间的全州合作伙伴关系,以应对阿片类药物流行:部落药物辅助治疗(MAT)关键信息提供者需求评估的初步结果。
J Subst Abuse Treat. 2020 Jan;108:9-19. doi: 10.1016/j.jsat.2019.04.003. Epub 2019 Apr 10.
3
Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample.美国印第安人和阿拉斯加原住民的阿片类药物使用障碍治疗药物:全国样本中的供应和使用情况。
Drug Alcohol Depend. 2021 Mar 1;220:108512. doi: 10.1016/j.drugalcdep.2021.108512. Epub 2021 Jan 19.
4
National Overview of Medication-Assisted Treatment for American Indians and Alaska Natives With Substance Use Disorders.美国印第安人和阿拉斯加原住民药物辅助治疗药物使用障碍的国家概况。
Psychiatr Serv. 2017 Nov 1;68(11):1136-1143. doi: 10.1176/appi.ps.201600397. Epub 2017 Jul 17.
5
Trending the evidence on opioid use disorder (OUD) continuum of care among rural American Indian/Alaskan Native (AI/AN) tribes: A systematic scoping review.农村美洲印第安人/阿拉斯加原住民(AI/AN)部落中阿片类药物使用障碍(OUD)连续护理的趋势:系统范围审查。
Addict Behav. 2021 Mar;114:106743. doi: 10.1016/j.addbeh.2020.106743. Epub 2020 Nov 28.
6
Provider perspectives on the impact of COVID-19 on treatment of substance use and opioid use disorders among American Indian and Alaska Native adults.提供者对 COVID-19 对美国印第安人和阿拉斯加原住民成年人的物质使用和阿片类药物使用障碍治疗的影响的看法。
Front Public Health. 2024 Jun 5;12:1356033. doi: 10.3389/fpubh.2024.1356033. eCollection 2024.
7
Drug, Opioid-Involved, and Heroin-Involved Overdose Deaths Among American Indians and Alaska Natives - Washington, 1999-2015.美国印第安人和阿拉斯加原住民的药物、阿片类药物和海洛因相关的过量死亡-华盛顿,1999-2015 年。
MMWR Morb Mortal Wkly Rep. 2018 Dec 21;67(50):1384-1387. doi: 10.15585/mmwr.mm6750a2.
8
Beyond the Belmont Principles: A Community-Based Approach to Developing an Indigenous Ethics Model and Curriculum for Training Health Researchers Working with American Indian and Alaska Native Communities.超越贝尔蒙原则:以社区为基础制定培训与美洲印第安人和阿拉斯加原住民社区合作的卫生研究人员的土著伦理模式和课程。
Am J Community Psychol. 2019 Sep;64(1-2):9-20. doi: 10.1002/ajcp.12360. Epub 2019 Jul 29.
9
Reconsidering culturally competent approaches to American Indian healing and well-being.重新审视针对美国印第安人康复与福祉的文化胜任方法。
Qual Health Res. 2015 Apr;25(4):486-99. doi: 10.1177/1049732314551056. Epub 2014 Sep 19.
10
Centering culture in the treatment of opioid use disorder with American Indian and Alaska Native Communities: Contributions from a National Collaborative Board.以美国印第安人和阿拉斯加原住民社区为中心治疗阿片类药物使用障碍:国家合作委员会的贡献。
Am J Community Psychol. 2023 Mar;71(1-2):174-183. doi: 10.1002/ajcp.12620. Epub 2022 Aug 23.

引用本文的文献

1
Tribally-affiliated syringe services programs in the United States: a brief report.美国部落附属注射器服务项目:简要报告
Harm Reduct J. 2025 Aug 19;22(1):143. doi: 10.1186/s12954-025-01296-8.
2
Conducting an implementation intervention study with American Indian and Alaska Native communities: Methodological considerations.对美国印第安人和阿拉斯加原住民社区进行实施干预研究:方法学考量
Contemp Clin Trials. 2025 Aug;155:107992. doi: 10.1016/j.cct.2025.107992. Epub 2025 Jun 20.
3
Quantifying the size and characteristics of a population of people who use drugs on the reservation lands of a tribal nation in the southern plains (USA).对美国南部平原一个部落国家保留地内吸毒人群的规模和特征进行量化。
Harm Reduct J. 2025 Apr 4;22(1):48. doi: 10.1186/s12954-025-01194-z.
4
An Introduction to Traditional Healing in American Indian and Alaska Native Communities.美洲印第安人和阿拉斯加原住民社区传统疗法介绍
MedEdPORTAL. 2025 Mar 7;21:11506. doi: 10.15766/mep_2374-8265.11506. eCollection 2025.
5
Content analysis of perceptions of combined pharmacobehavioral treatment for American Indian people with opioid use disorder.对患有阿片类药物使用障碍的美国印第安人联合药物行为治疗认知的内容分析
Psychol Addict Behav. 2025 Feb;39(1):1-13. doi: 10.1037/adb0001037. Epub 2025 Jan 9.
6
How Etuaptmumk/Two-Eyed Seeing is used in indigenous health research: A scoping review.本土健康研究中如何使用 Etuaptmumk/Two-Eyed Seeing:范围综述。
PLoS One. 2024 Sep 19;19(9):e0310247. doi: 10.1371/journal.pone.0310247. eCollection 2024.
7
Quantifying the Burden of Opioid Use Disorder and Non-fatal Opioid Overdose in American Indian and Alaskan Native Populations Using the Cerner Real-World Data™ Database.使用Cerner真实世界数据™数据库量化美国印第安人和阿拉斯加原住民中阿片类药物使用障碍和非致命性阿片类药物过量的负担。
J Racial Ethn Health Disparities. 2024 Aug 14. doi: 10.1007/s40615-024-02084-z.
8
Opioid use disorder and role of yoga as an adjunct in management (OUDARYAM): Study protocol for a randomized controlled trial.阿片类药物使用障碍与瑜伽作为辅助治疗手段的作用(OUDARYAM):一项随机对照试验的研究方案
Wellcome Open Res. 2024 Jan 3;9:4. doi: 10.12688/wellcomeopenres.19392.1. eCollection 2024.
9
Provider perspectives on the impact of COVID-19 on treatment of substance use and opioid use disorders among American Indian and Alaska Native adults.提供者对 COVID-19 对美国印第安人和阿拉斯加原住民成年人的物质使用和阿片类药物使用障碍治疗的影响的看法。
Front Public Health. 2024 Jun 5;12:1356033. doi: 10.3389/fpubh.2024.1356033. eCollection 2024.
10
Wiidookaage'win: Beta-test of a Facebook group intervention for Native women to support opioid use recovery.Wiidookaage'win:一个针对原住民女性的 Facebook 群组干预措施的β测试,以支持阿片类药物使用康复。
J Subst Use Addict Treat. 2024 Aug;163:209396. doi: 10.1016/j.josat.2024.209396. Epub 2024 May 15.

本文引用的文献

1
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.长效纳曲酮与丁丙诺啡-纳洛酮预防阿片类药物复发的比较效果(X:BOT):一项多中心、开放标签、随机对照试验。
Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. Epub 2017 Nov 14.
2
National Overview of Medication-Assisted Treatment for American Indians and Alaska Natives With Substance Use Disorders.美国印第安人和阿拉斯加原住民药物辅助治疗药物使用障碍的国家概况。
Psychiatr Serv. 2017 Nov 1;68(11):1136-1143. doi: 10.1176/appi.ps.201600397. Epub 2017 Jul 17.
3
Cannabis as a substitute for prescription drugs - a cross-sectional study.大麻作为处方药的替代品——一项横断面研究。
J Pain Res. 2017 May 2;10:989-998. doi: 10.2147/JPR.S134330. eCollection 2017.
4
Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?阿片类物质使用障碍的初级保健管理:禁欲、美沙酮还是丁丙诺啡-纳洛酮?
Can Fam Physician. 2017 Mar;63(3):200-205.
5
Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.安大略省西北部6个基于社区的偏远原住民丁丙诺啡项目评估:回顾性研究。
Can Fam Physician. 2017 Feb;63(2):137-145.
6
Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients.医用大麻的获取、使用以及对处方阿片类药物和其他物质的替代:对合法医用大麻患者的一项调查
Int J Drug Policy. 2017 Apr;42:30-35. doi: 10.1016/j.drugpo.2017.01.011. Epub 2017 Feb 9.
7
Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.药物和阿片类药物滥用相关过量死亡人数增加 - 美国,2010-2015 年。
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452. doi: 10.15585/mmwr.mm655051e1.
8
The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.行为干预在丁丙诺啡维持治疗中的作用:综述
Am J Psychiatry. 2017 Aug 1;174(8):738-747. doi: 10.1176/appi.ajp.2016.16070792. Epub 2016 Dec 16.
9
Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.基于初级保健的阿片类物质使用障碍治疗模式:一项范围综述
Ann Intern Med. 2017 Feb 21;166(4):268-278. doi: 10.7326/M16-2149. Epub 2016 Dec 6.
10
Research as Cultural Renewal: Applying Two-Eyed Seeing in a Research Project about Cultural Interventions in First Nations Addictions Treatment.作为文化复兴的研究:在一个关于原住民成瘾治疗文化干预的研究项目中应用双眼看理论。
Int Indig Policy J. 2015 May 1;6(2):1-15. doi: 10.18584/iipj.2015.6.2.4.

针对美国印第安人/阿拉斯加原住民的阿片类药物使用障碍的药物辅助治疗的未来方向。

Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives.

机构信息

Department of Psychology and Center on Alcoholism, Substance Abuse, and Addictions, University of New Mexico, MSC03 2220, Albuquerque, NM 87131, USA.

Alcohol & Drug Abuse Institute and Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine, 1107 NE 45th Street, Suite 120, Seattle, WA 98105-4631, USA.

出版信息

Addict Behav. 2018 Nov;86:111-117. doi: 10.1016/j.addbeh.2018.05.017. Epub 2018 May 23.

DOI:10.1016/j.addbeh.2018.05.017
PMID:29914717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6129390/
Abstract

The U.S. is experiencing an alarming opioid epidemic, and although American Indians and Alaska Natives (AI/ANs) are especially hard hit, there is a paucity of opioid-related treatment research with these communities. AI/ANs are second only to Whites in the U.S. for overdose mortality. Thus, the National Institute on Drug Abuse convened a meeting of key stakeholders to elicit feedback on the acceptability and uptake of medication assisted treatment (MAT) for opioid use disorders (OUDs) among AI/ANs. Five themes from this one-day meeting emerged: 1) the mismatch between Western secular and reductionistic medicine and the AI/AN holistic healing tradition; 2) the need to integrate MAT into AI/AN traditional healing; 3) the conflict between standardized MAT delivery and the traditional AI/AN desire for healing to include being medicine free; 4) systemic barriers; and 5) the need to improve research with AI/ANs using culturally relevant methods. Discussion is organized around key implementation strategies informed by these themes and necessary for the successful adoption of MAT in AI/AN communities: 1) type of medication; 2) educational interventions; 3) coordination of care; and 4) adjunctive psychosocial counseling. Using a community-based participatory research approach is consistent with a "two eyed seeing" approach that integrates Western and Indigenous worldviews. Such an approach is needed to develop impactful research in collaboration with AI/AN communities to address OUD health disparities.

摘要

美国正经历着一场令人震惊的阿片类药物泛滥危机,尽管美洲印第安人和阿拉斯加原住民(AI/ANs)受到的打击尤为严重,但针对这些社区的阿片类药物相关治疗研究却很少。在药物过量死亡率方面,AI/ANs在美国仅低于白人。因此,美国国家药物滥用研究所召集了一次主要利益攸关方会议,以征求他们对阿片类药物使用障碍(OUDs)药物辅助治疗(MAT)在 AI/ANs 中接受度和采用度的反馈。这次为期一天的会议得出了五个主题:1)西方世俗和还原论医学与 AI/AN 整体治疗传统之间的不匹配;2)需要将 MAT 融入 AI/AN 传统治疗中;3)标准化 MAT 提供与 AI/AN 传统中渴望治愈、避免用药之间的冲突;4)系统性障碍;5)需要使用与文化相关的方法改进针对 AI/ANs 的研究。讨论围绕这些主题提出的关键实施策略展开,这些策略对于在 AI/AN 社区成功采用 MAT 至关重要:1)药物类型;2)教育干预;3)护理协调;4)辅助心理社会咨询。采用基于社区的参与式研究方法符合“双眼观察”的方法,该方法融合了西方和土著世界观。为了解决 OUD 健康差距问题,需要与 AI/AN 社区合作开展有影响力的研究,这种方法是必要的。